Arrowhead Research reported $0 in Debt for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Agios Pharmaceuticals AGIO:US $ 0.65M 0.08M
Alnylam Pharmaceuticals ALNY:US $ 191.28M 191.28M
Arena Pharmaceuticals ARNA:US $ 45.61M 1M
Arrowhead Research ARWR:US $ 0M 0M
Bluebird Bio BLUE:US $ 0M 0M
Cerulean Pharma CERU:US $ 0.37M 0M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Heron Therapeutics HRTX:US $ 7.05M 0.42M
Intercept Pharmaceuticals ICPT:US $ 560.58M 7.37M
Ligand Pharmaceuticals LGND:US $ 448.89M 6.09M
Merk MRK:US $ 31791M 3050M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US 134.2M 25.59M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NOVN:VX SF 38049M 126M
Opko Health OPK:US $ 255.79M 15M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 1.16M 1.16M
Vertex Pharmaceuticals VRTX:US $ 581.48M 34.96M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 34.86M 11.87M